ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
-0,05%
Bitcoin
66.062,37
0,09%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Incyte Corporation (INCY)

  7. Incyte Corporation (INCY) News

INCY

Incyte (INCY)

Incyte Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:INCY
DatumZeitQuelleÜberschriftSymbolFirma
15/06/202400h23Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:INCYIncyte Corporation
14/06/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
14/06/202418h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
14/06/202418h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
14/06/202418h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
14/06/202418h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
14/06/202418h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
14/06/202418h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
14/06/202418h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
14/06/202418h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
14/06/202415h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INCYIncyte Corporation
13/06/202414h16Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:INCYIncyte Corporation
13/06/202414h00Business WireIncyte Announces Final Results of Tender OfferNASDAQ:INCYIncyte Corporation
12/06/202422h59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INCYIncyte Corporation
11/06/202414h16Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:INCYIncyte Corporation
11/06/202414h00Business WireIncyte Announces Preliminary Results of Tender OfferNASDAQ:INCYIncyte Corporation
10/06/202418h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INCYIncyte Corporation
07/06/202422h30Business WireIncyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:INCYIncyte Corporation
06/06/202422h40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INCYIncyte Corporation
04/06/202423h29Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:INCYIncyte Corporation
30/05/202422h05Business WireIncyte Completes Acquisition of Escient PharmaceuticalsNASDAQ:INCYIncyte Corporation
30/05/202421h12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INCYIncyte Corporation
21/05/202419h15Business WireIncyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office BuildingsNASDAQ:INCYIncyte Corporation
21/05/202414h00Business WireIncyte to Present at Upcoming Investor ConferenceNASDAQ:INCYIncyte Corporation
16/05/202403h45Business WireIncyte präsentiert Daten aus seinem Onkologie-Portfolio beim Jahrestreffen 2024 der ASCO und beim EHA2024 CongressNASDAQ:INCYIncyte Corporation
15/05/202417h44Business WireIncyte présentera les données de son portefeuille d'oncologie lors de la réunion annuelle 2024 de l'ASCO et du congrès EHA2024NASDAQ:INCYIncyte Corporation
15/05/202417h10Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:INCYIncyte Corporation
14/05/202423h00Business WireIncyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 CongressNASDAQ:INCYIncyte Corporation
14/05/202415h05IH Market NewsProducer Price Inflation Data May Weigh On Wall StreetNASDAQ:INCYIncyte Corporation
14/05/202400h06Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:INCYIncyte Corporation
 Showing the most relevant articles for your search:NASDAQ:INCY

Kürzlich von Ihnen besucht

CCOM
US500
US 500
FX
EURJPY
Euro vs Yen
TG
LHA
Deutsche Lufthansa
CCOM
US30
US 30
NYSE
KO
Coca Cola
NYSE
MRK
Merck
AMEX
XLE
Energy Select Sector SPDR
TG
MBG
MercedesBenz
NYSE
XOM
Exxon Mobil
TG
NOV
Novo Nordisk
COIN
BTCUSD
Bitcoin
FX
EURGBP
Euro vs Sterling
TG
RHM
Rheinmetall
TG
BAS
BASF
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten